New cancer drug begins clinical trial in human patients with rare brain tumor
Medical news life sciences | November 28, 2017
A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma, a rare malignant brain tumor, and glioblastoma multiforme, an aggressive late-stage cancer of the brain.